Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Managing chromoblastomycosis with acitretin plus imiquimod: A case report on the improvement of cutaneous lesions and reduction of the treatment time
Walter Belda, Ana Thereza Stradioto Casolato, Juliana Bronzato Luppi, et al.
The Journal of Dermatology (2021) Vol. 48, Iss. 10, pp. 1612-1615
Closed Access | Times Cited: 10

Showing 10 citing articles:

Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis
Luiz Felipe Domingues Passero, Italo Novais Cavallone, Walter Belda
Journal of Immunology Research (2021) Vol. 2021, pp. 1-23
Open Access | Times Cited: 32
Chromoblastomycosis: New Perspective on Adjuvant Treatment with Acitretin
Walter Belda, Luiz Felipe Domingues Passero, Caroline Carvalho, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 162-162
Open Access | Times Cited: 3
Successful Management of Chromoblastomycosis Utilizing Conventional Antifungal Agents and Imiquimod Therapy
Jinjin Zheng, Shougang Liu, Zhengmou Xie, et al.
Research Square (Research Square) (2024)
Open Access
Chromoblastomycosis in Brazil: A review of 450 published cases
LAYALA STEFANE DE PAULA BARBOSA, Yury Raphaell Coringa de Souza, Caroline Suemi Sasaki, et al.
Revista da Sociedade Brasileira de Medicina Tropical (2024) Vol. 57
Open Access
Successful management of chromoblastomycosis utilizing conventional antifungal agents and imiquimod therapy
Jinjin Zheng, Shougang Liu, Zhenmou Xie, et al.
Annals of Clinical Microbiology and Antimicrobials (2024) Vol. 23, Iss. 1
Open Access
Chromoblastomycosis caused by Alternaria infectoria, concurrent with myiasis, in a recipient of a kidney transplant: a compelling case report
Hamidreza Mahmoudi, Zahra Ramezanalipour, Mahmoud Ghazi Khansari, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Triple therapy approach for treating chromoblastomycosis in a Lebanese patient
Joe Khodeir, Paul Ohanian, Hala Mégarbané
Clinical Case Reports (2024) Vol. 12, Iss. 10
Open Access
Análise comparativa do perfil citocínico Th22 na imunopatogenia da doença de Jorge Lobo e cromomicose
Clivia Maria Moraes de Oliveira
(2023)
Open Access
New Immunological Markers in Chromoblastomycosis—The Importance of PD-1 and PD-L1 Molecules in Human Infection
Italo Novais Cavallone, Walter Belda, Caroline Carvalho, et al.
Journal of Fungi (2023) Vol. 9, Iss. 12, pp. 1172-1172
Open Access
Multiple drugs

Reactions Weekly (2021) Vol. 1879, Iss. 1, pp. 253-253
Closed Access
Page 1

Scroll to top